TapewireFind a company

person · Reporting owner

Christiansen Andrew

Disclosed activity across 1 company

Tapewire entity
111270
SEC CIK
0001805400

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Cardlytics, Inc.CDLX · Entity 7603Chief Financial OfficerJuly 18, 2023July 20, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cardlytics, Inc.

Report date July 18, 2023 · Filed July 20, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect70,775 Ending reported balance After 2023-07-19 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2023-07-18 · Exercise / conversion · Acquired 30,147 · Balance 84,179

F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Row 2 · 2023-07-19 · Sale · Disposed 13,404 · Balance 70,775

F2: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2023-07-18 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2023-07-18 · Exercise / conversion · Acquired 30,147 · Balance 0

F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F5: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

F2: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F5: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 19, 2023 Filed Jul 20, 2023 16:10 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 13,404 $10.20 $136,720.80
Disclosure

SEC source: 0001666071-23-000097 · wk-form4_1689883832.xml · nonDerivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,775

F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Read SEC document
July 18, 2023 Filed Jul 20, 2023 16:10 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 30,147 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000097 · wk-form4_1689883832.xml · derivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,147 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F5 · derivative.exercise_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F5 · derivative.expiration_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 16:10 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 30,147 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000097 · wk-form4_1689883832.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
June 23, 2023 Filed Jun 26, 2023 18:31 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 649 $5.68 $3,686.32
Disclosure

SEC source: 0001666071-23-000078 · wk-form4_1687818703.xml · nonDerivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,032

F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on June 22, 2023.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 18:31 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 2,034 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000078 · wk-form4_1687818703.xml · derivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,034 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F4 · derivative.exercise_date: 25% of the RSUs shall vest on March 22, 2023 with the remainder vesting in twelve equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: 25% of the RSUs shall vest on March 22, 2023 with the remainder vesting in twelve equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 18:31 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 2,034 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000078 · wk-form4_1687818703.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
April 05, 2023 Filed May 3, 2023 21:31 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 3,409 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027209 · doc4.xml · derivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,818

Underlying: Common Stock · 3,409 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F2 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F2 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
April 05, 2023 Filed May 3, 2023 21:31 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 3,409 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-027209 · doc4.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 16:10 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 9,677 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · derivative · entry 4

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,677

Underlying: Common Stock · 9,677 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 16:10 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 9,677 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · nonDerivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,238

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
March 22, 2023 Filed Apr 4, 2023 16:10 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 8,136 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · derivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,411

Underlying: Common Stock · 8,136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
March 22, 2023 Filed Apr 4, 2023 16:10 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 8,136 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000049 · wf-form4_168063897672513.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 16:09 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 8,137 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000002 · wf-form4_167364418422216.xml · derivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,137 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award.

F3 · derivative.expiration_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 16:09 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 8,137 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000002 · wf-form4_167364418422216.xml · derivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,137

Underlying: Common Stock · 8,137 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award.

F3 · derivative.expiration_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 16:09 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 8,137 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000002 · wf-form4_167364418422216.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 17:31 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000159 · wf-form4_167097064105132.xml · derivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 12 months after the Certification.

F2 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 12 months after the Certification.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 17:31 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000159 · wf-form4_167097064105132.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 08, 2022 Filed Nov 8, 2022 16:52 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 68 $4.00 $271.66
Disclosure

SEC source: 0001666071-22-000142 · wf-form4_166794431813983.xml · nonDerivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,413

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

Read SEC document
November 07, 2022 Filed Nov 8, 2022 16:52 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,234 $4.32 $5,330.88
Disclosure

SEC source: 0001666071-22-000142 · wf-form4_166794431813983.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,481

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.17 to $4.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 06, 2022 Filed Nov 3, 2022 16:13 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000138 · wf-form4_166750637805639.xml · derivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification.

F3 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification.

Read SEC document
October 06, 2022 Filed Nov 3, 2022 16:13 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000138 · wf-form4_166750637805639.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
August 05, 2022 Filed Aug 8, 2022 16:37 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 589 $14.90 $8,776.10
Disclosure

SEC source: 0001666071-22-000109 · wf-form4_165999102243417.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,840

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on June 9, 2022.

F2 · balance_after: Includes 291 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 16:57 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantRestricted Stock Units · Derivative 30,147 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000091 · wf-form4_165835062741159.xml · derivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,147

Underlying: Common Stock · 30,147 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F5 · derivative.exercise_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F5 · derivative.expiration_date: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
June 09, 2022 Filed Jul 20, 2022 16:57 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000091 · wf-form4_165835062741159.xml · derivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F3 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
June 09, 2022 Filed Jul 20, 2022 16:57 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000091 · wf-form4_165835062741159.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,138

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
May 10, 2022 Filed May 10, 2022 16:38 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 250 $29.20 $7,300.00
Disclosure

SEC source: 0001666071-22-000065 · wf-form4_165221507107163.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,263

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021.

Read SEC document
May 05, 2022 Filed May 9, 2022 16:08 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 4,634 $34.64 $160,521.76
Disclosure

SEC source: 0001666071-22-000060 · wf-form4_165212687893669.xml · nonDerivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,513

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $34.37 to $34.94, inclusive.

Read SEC document
May 05, 2022 Filed May 9, 2022 16:08 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 4,686 $34.13 $159,933.18
Disclosure

SEC source: 0001666071-22-000060 · wf-form4_165212687893669.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,147

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.37 to $34.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
April 11, 2022 Filed Apr 11, 2022 16:05 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 250 $46.75 $11,687.50
Disclosure

SEC source: 0001666071-22-000046 · wf-form4_164970748986527.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,833

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021.

Read SEC document
April 06, 2022 Filed Apr 7, 2022 19:23 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · derivative · entry 4

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F5 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F5 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
April 06, 2022 Filed Apr 7, 2022 19:23 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 1,875 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · nonDerivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,083

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
April 05, 2022 Filed Apr 7, 2022 19:23 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 3,408 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · derivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,227

Underlying: Common Stock · 3,408 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
April 05, 2022 Filed Apr 7, 2022 19:23 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 3,408 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000037 · wf-form4_164937377602615.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:54 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 9,678 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000033 · wf-form4_164919204547998.xml · derivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,355

Underlying: Common Stock · 9,678 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 16:54 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 9,678 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000033 · wf-form4_164919204547998.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Read SEC document
March 24, 2022 Filed Mar 24, 2022 19:51 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantCommon Stock 2,017 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000029 · wf-form4_164816588107192.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,122

F1 · shares: Represents a restricted stock unit ("RSU") award. The shares underlying the RSU award vested immediately upon grant.

Read SEC document
March 22, 2022 Filed Mar 24, 2022 19:51 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantRestricted Stock Units · Derivative 32,547 $0.00 $0.00
Disclosure

SEC source: 0001666071-22-000029 · wf-form4_164816588107192.xml · derivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,547

Underlying: Common Stock · 32,547 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F3 · derivative.exercise_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F3 · derivative.expiration_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
March 10, 2022 Filed Mar 10, 2022 16:30 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 250 $52.97 $13,242.50
Disclosure

SEC source: 0001666071-22-000024 · wf-form4_164694779046376.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,105

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021.

Read SEC document
February 10, 2022 Filed Feb 11, 2022 21:48 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 250 $70.00 $17,500.00
Disclosure

SEC source: 0001666071-22-000009 · wf-form4_164463407090421.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,355

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2021.

Read SEC document
January 10, 2022 Filed Jan 11, 2022 16:26 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 250 $61.02 $15,255.00
Disclosure

SEC source: 0001666071-22-000003 · wf-form4_164193636492717.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,605

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 16:19 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 380 $69.63 $26,459.40
Disclosure

SEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 5

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,855

F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021.

F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $69.28 to $70.13, inclusive.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 16:19 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 820 $68.66 $56,301.20
Disclosure

SEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 4

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,235

F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021.

F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $68.18 to $69.08, inclusive.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 16:19 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 539 $67.62 $36,447.18
Disclosure

SEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,055

F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.18 to $68.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5) and (6) to this Form 4.

Read SEC document
December 10, 2021 Filed Dec 13, 2021 16:19 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 250 $71.45 $17,862.50
Disclosure

SEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 2

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,594

F2 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 16:19 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 3,750 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · derivative · entry 7

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F7 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F7 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 16:19 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · derivative · entry 6

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F7 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

F7 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 16:19 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-21-000240 · wf-form4_163943032718553.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 10, 2021 Filed Nov 10, 2021 16:07 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 250 $88.41 $22,102.50
Disclosure

SEC source: 0001666071-21-000228 · wf-form4_163657842402014.xml · nonDerivative · entry 1

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,094

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 17:26 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 200 $92.96 $18,592.00
Disclosure

SEC source: 0001666071-21-000222 · wf-form4_163641037425146.xml · nonDerivative · entry 4

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,344

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021.

F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $92.94 to $92.98, inclusive.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 17:26 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 150 $92.11 $13,816.50
Disclosure

SEC source: 0001666071-21-000222 · wf-form4_163641037425146.xml · nonDerivative · entry 3

Christiansen Andrew · CIK 0001805400 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,544

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $91.88 to $92.5725, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.